Hyris

Hyris is an innovation-based, global biotech Company, which aims to
democratize genetic analysis.

[Hyris @HyrisLtd]

Hyris and P.Intertrade will partner together to commercialize Hyris signature technology, Hyris System, and Hyris testing solutions in Thailand.

Visit our website to know more

https://t.co/KrBI2W5gdL

https://t.co/a28ki45lvA

#hyris #pintertrade #hyrissystem #thailand

[Hyris @HyrisLtd]

Tomorrow Hyris will hold a presentation at SEI2022, discussing the approach behind the development of Hyris T Cells test.

Pass by Sala Palacìn 2 at 1pm if you are attending SEI 2022.

Visit https://t.co/G1W7kYB28I to know more.

#sei22 #tcells #covid19 #sarscov2 #pcr

[Hyris @HyrisLtd]

SAVE THE DATE! @HyrisLtd will be present at the upcoming SEI 2022 to show the scientific approach related to our new T Cell test to monitor the cellular immunity to SARS-CoV-2.

https://t.co/1GTcypBAI6

#hyris #hyrissystem #tcells #sarscov2 #covid19 #healthcare #pcr
#diagnostics

[Hyris @HyrisLtd]

@Hyris new #T-Cell Test is finally available for the EU Market after receiving the #CE-IVD mark. Fruit of months of experimentations, the Test answer the key question: How long will my COVID19-Immunity last, whether from a vaccine or prior infection?
#qPCR #Immunity #HyrisSystem

[Hyris @HyrisLtd]

Hyris' New T-Cell Test is Finally Available to EU Countries to Easily Map Patients' Cellular Immunity to SARS- ... https://t.co/ImqTdY1tgR

[Rishi Goel @rishirajgoel]

Wonderful summary of anti-SARS-CoV-2 immunity by @profshanecrotty @SetteLab

[Alessandro Sette @SetteLab]

Great collaboration and further evidence of cd4 responses in respiratory infection and diseases in general and in TB in particular

[Hyris @HyrisLtd]

All setup for @HyrisLtd at booth A3.115 at @analyticaFair 2022.

#analytica #hyris #hyrissystem

[Duke-NUS Medical School @dukenus]

A new study by a group of international researchers found a way to assess #covid19 immunity through a blood test that can measure T cells. https://t.co/fIBJQYP6Qs.

#dukenusresearch #sarscov2 #coronavirus @Anto_Berto @bertoletti_lab

[Hyris @HyrisLtd]

A New T-Cell activation assay based on Hyris qPCR Technology marks a disruptive approach for the detection of ... https://t.co/zcTt9KPxUE

[Nature Biotechnology @NatureBiotech]

@IcahnMountSinai @TischCancer @dukenus @astar_research @SaludISCIII @IdipazScience @IDIVALdecilla @Anto_Berto @sema4 @HyrisLtd A new test can help reveal if you're immune to COVID-19 #NBTintheNews via @TIME https://t.co/ln5ARYMkVD

[Nature Biotechnology @NatureBiotech]

Rapid, scalable assessment of SARS-CoV-2 cellular immunity by whole-blood PCR https://t.co/qM7hyTNr5w

[Hyris @HyrisLtd]

We’re honored for this collaboration with such prestigious partners @bertoletti_lab @GuccioneLab. More to come about this test on the market! #covid #SARSCoV2 #TCELL #hyris #pcr

[Bertoletti Lab @bertoletti_lab]

Easy and scalable qPCR assays to measure SARS-CoV-2-specific T cells. Nice collaboration with our US-based friends @GuccioneLab and Jordi Ochando!
And thanks to @HyrisLtd for bringing it to the market...now everyone can test their hypotheses ;)

[Hyris @HyrisLtd]

Come and visit us at Analytica 2022.

We'll present Hyris System: a smart, efficient and scalable diagnostic solution, with real-time access to results already interpreted AI cloud software.

#analytica2022 #hyris #hyrissystem #diagnostics #pcr #biotechnology

[Bertoletti Lab @bertoletti_lab]

Half of all COVID-19 vaccine doses worldwide are based on inactivated viruses (Sinovac-CoronaVac & Sinopharm)...and we know very little about their induced T cell response.
Here is our characterization of T cells triggered by inactivated and mRNA vaccines
https://t.co/U3or6YEgAn

[CRID @cam_crid]

Happening now! Lorenzo Colombo,CTO at @HyrisLtd presenting the #bCUBE system and it's field applications during the #bCUBE annual meeting & scientific symposium organised at @cam_crid.
@JohnsHopkinsSPH, @gatesfoundation @PMIVectorLink @LSTMvector

[CRID @cam_crid]

Lorenzo Colombo,CTO at @HyrisLtd & collaborators from @JohnsHopkinsSPH presenting the #bCUBE system & machine as well as on how to design primers for #bCUBE during the #bCUBE annual meeting organised at @cam_crid in collaboration with @gatesfoundation @JohnsHopkinsSPH & @HyrisLtd

[CRID @cam_crid]

From May 30th - June 3rd,2022,@cam_crid is hosting at its premises a technical meeting & scientific symposium with collaborators from @JohnsHopkins & @HyrisLtd under the theme: Biology of vector-borne pathogens & development of new detection tools. @gatesfoundation @lstm_ccr

[CRID @cam_crid]

May 30,2022,Day 1:Prof @cwondji,CEO at @cam_crid & Prof. of Genetics & Vector Biology at #LSTM presenting on @cam_crid,it's research activities & facilities during the technical meetx organised in collaboration with partners from @JohnsHopkins & @HyrisLtd.#bCUBE @gatesfoundation

[CRID @cam_crid]

Prof George Dimopoulos, @MosquitoExpert, Prof at @JohnsHopkinsSPH presenting an overview of the #bCUBE project & its objectives during the #bCUBE annual technical meetx organised at @cam_crid,Yaoundé #Cameroon in collaboration with the @gatesfoundation, @HyrisLtd & @JohnsHopkins